Hangzhou NeuroPeptide Biological Science and Technology Incorporation
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- Undisclosed
Investors
- 3
About Hangzhou NeuroPeptide Biological Science and Technology Incorporation
Established in 2009 and based in Hangzhou, China, Hangzhou NeuroPeptide Biological Science and Technology Incorporation, Ltd. operates as a protein purification filler service provider. The company awarded as "National High-Tech Enterprise", "The top 100 most growing technology company" and "Rishang Province Science and Technology Enterprise". The company passed ISO9001 quality management system certification. The company provides active protein and polypeptide products for many fields such as separation and purification of protein drugs, diagnostic reagents and cell culture. The company's products include protein, chromato, affinity filer and pre-activated filer. Protein products include NRPA33 r-SA2, NRPA34 r-SA3 and NRPA35 r-cSA3. Affinity filer products include NRPB44 Biotin NUPharose FF, NRPB60 ee-SA NUPharose FF and NRPB76L IMAC NUPharose FF. The business of company includes R&D, production and sale of bioactive protein, peptide biologics and bioseparation materials.
Who invested in Hangzhou NeuroPeptide Biological Science and Technology Incorporation
3 investors across 1 round
See all investors in Hangzhou NeuroPeptide Biological Science and Technology Incorporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 9, 2022
Amount
Undisclosed
Investors
Questions about Hangzhou NeuroPeptide Biological Science and Technology Incorporation
Who invested in Hangzhou NeuroPeptide Biological Science and Technology Incorporation?
Hangzhou NeuroPeptide Biological Science and Technology Incorporation has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou NeuroPeptide Biological Science and Technology Incorporation raised?
Hangzhou NeuroPeptide Biological Science and Technology Incorporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hangzhou NeuroPeptide Biological Science and Technology Incorporation last raise money?
Hangzhou NeuroPeptide Biological Science and Technology Incorporation's most recent round on record is a Series A, in Apr 2022.
What does Hangzhou NeuroPeptide Biological Science and Technology Incorporation do?
Established in 2009 and based in Hangzhou, China, Hangzhou NeuroPeptide Biological Science and Technology Incorporation, Ltd.
Where is Hangzhou NeuroPeptide Biological Science and Technology Incorporation headquartered?
Hangzhou NeuroPeptide Biological Science and Technology Incorporation is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou NeuroPeptide Biological Science and Technology Incorporation?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hangzhou NeuroPeptide Biological Science and Technology Incorporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hangzhou NeuroPeptide Biological Science and Technology Incorporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.